Skip to content

Welcome

The Pharmacy and Poisons Board of Hong Kong (the Board) is established under section 3 of the Pharmacy and Poisons Ordinance (Cap. 138, Laws of Hong Kong) to carry out functions in accordance with the provisions of the said Ordinance and its subsidiary legislation.
 

What's New

• Consultation on the Implementation of Good Distribution Practice (GDP) for Pharmaceutical Products >>
• Results of the December 2025 Pharmacist Registration Examinations >>
• Asia Summit on Global Health (11-12 May 2026) >>
• Application for June 2026 Pharmacist Registration Examinations >>
• Refine the Requirements for Applications for Change of Registered Particulars Related to Indication, Dosage and Route of Administration >>
• Probity requirements for licensed traders under the Pharmacy and Poisons Ordinance (Cap. 138) >>
• Revised Code of Professional Conduct for The Guidance of Registered Pharmacists in Hong Kong >>
• Revised Specified Form of Free Sale Certificate of Pharmaceutical Product with effect from 1 July 2025 >>
• Revised Specified Form of Certificate of Manufacturer with effect from 1 July 2025 >>
• List of Pharmaceutical Products Registered Under "1+" Mechanism
• Extending the "1+" mechanism to all new drugs on November 1
• Extending the “1+” Mechanism for Applications for Registration of Pharmaceutical Products containing New Chemical or Biological Entities
• PRC Letters from year 2015 (Indexed by Date) >>
• PRC Letters from year 2015 (Indexed by Ingredient) >>
• Regulation of Medical Gases
• List of Certificate for Clinical Trial/Medicinal Test issued related to COVID-19
• List of Certificate for Clinical Trial/Medicinal Test issued since January 2022 >>
• Pharmacy and Poisons Board of Hong Kong, Hong Kong, China Becomes ICH Observer >>
• "1+" mechanism for approval of new drugs to commence on November 1 >>
• Launch of Electronic Certificate of Drug/Product Registration on 1 July 2023 >>
• Scheduled Disciplinary Inquiry >>
• Regulation of Advanced Therapy Products >>
• Letter from the Secretary for Food and Health dated 4 February 2022 on Off-label Use of Comirnaty Vaccine on Children aged five to 11 >>
• Alert on Drugs >>
• Drug News >>
 
ICH Guidelines ImplementationEntry
Primary evaluationEntry
"1+" mechanismEntry
Regulation of Medical GasesEntry
Regulation of Advanced Therapy ProductsEntry
Directions given by the Disciplinary Committee against Authorized Sellers of Poisons Registered PharmacistsEntry
Suspension Notice of Listed Sellers of PoisonsEntry
Involvements of the Pharmacy and Poisons Board in Combating Antimicrobial ResistanceEntry
The Good Manufacturing Practice Guides for Licensed Pharmaceutical Manufacturers and Licensed Secondary Packaging Manufacturers Entry
Pharmacy and Poisons Board of Hong Kong accedes to Pharmaceutical Inspection Co-operation SchemeEntry
Report of the Review Committee on Regulation of Pharmaceutical Products in Hong KongEntry
Resource Centre – Corruption Prevention Advisory ServiceEntry
Top